KeyBanc analyst Aleksey Yefremov lowered the firm’s price target on Eastman Chemical to $96 from $98 and keeps an Overweight rating on the shares. Eastman believes destocking is now likely to be complete by the end of Q1/early Q2 but highlighted building and construction as the biggest question mark at the current juncture, the analyst tells investors in a research note. The firm continues to believe in the longer-term earnings potential of the Eastman portfolio and the ramp of its methanolysis project.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EMN:
Questions or Comments about the article? Write to editor@tipranks.com